Skip to main content

Table 2 Summary of the results of the ten different classification tasks.

From: Identification of lung cancer with high sensitivity and specificity by blood testing

Classification task Accuracy % Sensitivity
%
Specificity
%
lung cancer vs controls 97.6
(CI: 97.3-97.9)
97.9
(CI: 96.6-97.8)
97.0
(CI:97.6-98.3)
lung cancer stage IA/IB vs controls 92.9
(CI: 92.4-93.4)
75.9
(CI: 73.7-78.2)
97.6
(CI: 97.3-97.8)
lung cancer stage II, III, IV vs controls 97.6
(CI: 97.1-98.0)
99.9
(CI: 87.2-91.0)
89.1
(CI: 99.7-100.0)
lung cancer stage IA/IB vs lung cancer stage II, III, IV 66.5
(CI: 63.8-69.1)
65.7
CI: 62.2-69.2)
67.3
(CI: 64.6-70.0)
NSCLC vs controls 94.6
(CI: 93.9-95.2)
97.8
(CI: 97.5-98.2)
85.7
(CI: 83.8-87.5)
SCLC vs controls 95.7
(CI: 95.2-96.0)
99.3
(CI: 99.0-99.6)
79.4
(CI: 77.5-81.4)
NSCLC vs SCLC 67.3
(CI: 65.4-69.3)
76.7
(CI: 74.4-79.0)
52.2
(CI: 50.0-54.4)
lung cancer vs NTLP 88.5
(CI: 88.0-89.3)
99.8
(CI: 99.5-100.0)
42.4
(CI: 40.2-44.6)
lung cancer vs non-cancer 92.2
(CI: 91.6-92.9)
96.7
(CI: 95.5-97.9)
88.2
(CI: 87.5-88.8)
lung cancer vs COPD/emphysema 78.8
(CI: 78.0-79.7)
92.6
(CI: 91.6-93.5)
40.9
(CI: 38.8-43.0)
  1. Abbreviations: NSCLC = non-small cell lung cancer, SCLC = small cell lung cancer, NTLP = non-tumor lung pathology, controls = patients without any lung disease, non-cancer = controls and NTLP, CI = 95% Confidence Intervals